The Compositae plant, Calendula (C.) officinalis L., which is commonly called "Marigold", is widely cultivated as an ornamental. The flowers of this plant are very important in European and western Asian folk medicines and are used to treat inflammatory conditions of internal organs, gastrointestinal ulcers, and dysmenorrhea and as a diuretic and diaphoretic in convulsions. This natural medicine is also known to be used externally for inflammation of the oral and pharyngeal mucosa, wounds, and burns. As chemical constituents of C. officinalis, some triterpenes, triterpene oligoglycosides, and flavonol glycosides have been obtained from the flowers.
In the course of our studies on the bioactive principles of medicinal flowers, 1, 3) we found that the methanolic extract and its 1-butanol-soluble fraction from the dried flowers of Egyptian C. officinalis showed inhibitory effects on the increase of serum glucose levels in glucose-loaded mice, gastric emptying, and ethanol-induced gastric lesions. From the 1-butanol-soluble fraction, we have isolated four new triterpene oligoglycosides called calendasaponins A (1), B (2), C (3), and D (4), two new ionone glucosides named officinosides A and B, and two new sesquiterpene glycosides termed officinosides C and D. This paper deals with the structural elucidation of calendasaponins (1) (2) (3) (4) . In addition, we describe the inhibitory effects of the glycoside fraction and principal saponin constituents on the increase of serum glucose levels in glucose-loaded mice, gastric emptying, and ethanol-and indomethacin-induced gastric lesions.
The dried flowers of C. officinalis cultivated in Egypt were extracted with methanol under reflux. The methanol extract was partitioned into an ethyl acetate-water mixture to furnish the ethyl acetate-soluble fraction and water phase. The water phase was further extracted with 1-butanol to give a 1-butanol-soluble fraction (the glycoside fraction) and water-soluble fraction. The methanolic extract was found to exhibit inhibitory activity on the increase of serum glucose levels in glucose-loaded mice after a single oral administration of 1000 mg/kg. In the same bioassay, the 1-butanol-soluble fraction showed potent activity at a lower dose (500 mg/kg), as shown in Table 1 . As shown in Table 2 , the methanolic extract also inhibited gastric emptying in carboxymethyl cellulose sodium salt (CMC-Na) meal-loaded mice after an oral application (500, 1000 mg/kg). The 1-butanol-soluble fraction showed a potent inhibitory effect on gastric emptying at lower doses (250, 500 mg/kg). Furthermore, these extracts were found to show a potent gastroprotective effect in rats (Table 3) . Namely, the methanolic extract inhibited gastric lesions induced by ethanol after an oral application (100, 200 mg/kg) in rats, while the 1-butanol-soluble fraction was found to completely inhibit ethanol-induced gastric lesions at a 100 mg/kg dose. On the other hand, the methanolic extract and 1-butanol-soluble fraction completely inhibited indomethacin-induced gastric lesions. The 1-butanol-soluble fraction was subjected to normal-phase silica gel column chromatography to provide six fractions . Fractions 2-6 were separated by normal-phase and reversed-phase silica gel column chromatography and HPLC to give calendasaponins A (1, 0.0012%), B (2, 0.0024%), C (3, 0.0011%), and D (4, 0.0056%), officinosides A (0.0013%), B (0.0016%), C (0.0028%), and D (0.0028%), glycosides A (5, 2f) 0.090%), B (6, 2f) 0.080%), C (7, 2f) 0.085%), D (8, 2f) 0.060%), D 2 (9, 2f) 0.030%), F (10, 2f) 0.0091%), calenduloside D (11, 4) 0.0009%), arvensoside A (12, 5) 0.0014%), rutin (13, 6) 0.0025%), quercetin 3-O-neohesperidoside (14, 7) 0.0036%), quercetin 3-O-2 G -rhamnosylrutinoside (15, 8) 0.018%), isorhamnetin 3-O-glucoside (16, 9) 0.0015%), isorhamnetin 3-O-rutinoside (17, 7) 0.060%), isorhamnetin 3-O-neohesperidoside (18, 7) 0.0099%), isorhamnetin 3-O-2 G -rhamnosylrutinoside (19, 8) 0.024%), and icariside C 3 (20, 10) 0.0006%). [d 5.27 (d-like, 1ٞ-H) ]. In the HMBC experiments of 1, longrange correlations were observed between the anomeric proton (1Ј-H) of the glucopyranosiduronic acid moiety and the 3-carbon of the moronic acid moiety, between the anomeric proton (1Љ-H) of the glucopyranosyl moiety and the 2Ј-carbon of the glucopyranosiduronic acid moiety, between the anomeric proton (1ٞ-H) of the galactopyranosyl moiety and the 3Ј-carbon of the glucopyranosiduronic acid moiety, and Chart 3 between the anomeric proton (1ЉЉ-H) of the glucopyranosyl moiety and the 28-carbon of the moronic acid moiety. On the basis of this evidence, the structure of calendasaponin A was determined to be 28
Structures of Calendasaponins A (1), B (2), C (3), and D (4)
Calendasaponin B (2) was also isolated as colorless fine crystals of mp 245.6-247.0°C from MeOH-H 2 O, and its IR spectrum showed absorption bands due to hydroxyl and carbonyl functions. [d 6.19 (d, Jϭ7.9 Hz, ]. In the HMBC experiment of 2, long-range correlations were observed between the 1Ј-proton and the 3-carbon, between the 1Љ-proton and the 3Ј-carbon, and between the 1ٞ-proton and the 28-carbon. Furthermore, in the pNOESY experiment, NOE correlations were observed between the 1Ј-H and the 3-H, between the 1Љ-H and the 3Ј-H, and between the 27-H 3 and the 16-H. Based on this evidence, calendasaponin B was determined to be 28
Calendasaponins C ( 12) The proton and carbon signals in 1 H-NMR (pyridine-d 5 ) and 13 C-NMR (Table 4 ) spectra 13) of 3 and 4 were superimposable on those of 1 except for a few signals due to the sapogenol moiety. The NMR data of 3 and 4 showed signals assignable to a cochalic acid moiety 3, 4.54 (dd, Jϭ3.9, 16.8 Hz,  16-H), 5.42 (br s, 12-H)] for 3, and a machaerinic acid moiety 3, 3.89 (dd, Jϭ4.6, 11.6 Hz, 19) Furthermore, by examination of the structural requirement for hypoglycemic activity, the active saponins were found to be classified into the following three types of structure: 1) oleanen-28-oic acid 3-monodesmosides, 2) acylated polyhydroxyoleanene 3-monodesmosides, and 3) oleanene 3,28-acylated bisdesmosides. 20) Since the methanolic extract and 1-butanol-soluble fraction from the flowers of C. officinalis showed an inhibitory effect on the increase in serum glucose levels in oral glucose-loaded mice (Table 1) , we examined the hypoglycemic activity of the principle saponins, glycosides A (5), B (6), C (7), D (8), and F (10), from the 1-butanol-soluble fraction. As shown in Table 5 , two oleanolic acid 3-monodesmosides (8, 10) showed potent hypoglycemic activity after a single oral administration of 50 mg/kg in rats, while two oleanolic acid 3,28-bisdesmosides (5, 7) showed no activity. Contrary to our expectation, an oleanolic acid 3-monodesmoside (6) having a 2Ј-O-b-Dglucopyranosyl moiety showed no activity (Table 5 ). In a previous paper, we reported as an exception that an oleanolic acid 3-monodesmoside having a 2Ј-O-b-D-glucopyranosyl moiety (28-deglucopyranosyl-chikusetsusaponin V) did not inhibit the increase in serum glucose levels in oral glucoseloaded rats at a dose of 50 mg/kg. 21) Taking this evidence into account, the 2Ј-O-b-D-glucopyranosyl moiety was assumed to markedly reduce the hypoglycemic activity of oleanolic acid 3-monodesmoside.
Inhibitory Effects of Principle Saponins (5-8, 10) on Gastric Emptying in CMC-Na Meal-Loaded Mice
By investigation of the modes of action for the hypoglycemic activity of saponins, active saponins were found to inhibit gastric emptying and glucose uptake in the small intestine. 21, 22) In order to confirm the modes of action for the hypoglycemic activity, the effects of principle saponins on gastric emptying were examined. As shown in Table 6 , two oleanolic acid 3-monodesmosides (8, 10) with potent hypoglycemic activity significantly inhibited gastric emptying at doses of 12.5, 25, 50, and 100 mg/kg, whereas two oleanolic acid 3,28-bisdesmosides (5, 7) did not exhibit the activity at a dose of 50 mg/kg. Oleanolic acid 3-monodesmoside (6) with a 2Ј-Ob-D-glucopyranosyl moiety did not show the activity at doses of 12.5, 25, and 50 mg/kg, but weak inhibitory activity was observed at a dose of 100 mg/kg. No hypoglycemic activity of 6 may be attributed to its weak inhibitory activity on gas- Table 5 . Effects of Glycosides A (5), B (6), C (7), D (8) , and F (10) Table 6 . Effects of Glycosides A (5), B (6), C (7), D (8), and F (10) ; therefore we examined the gastroprotective effect of the methanolic extract, 1-butanolsoluble portion, and principle saponins (5) (6) (7) (8) 10) . By intragastric or subcutaneous administration of ethanol (1.5 mg/rat) or indomethacin (30 mg/kg), marked gross gastric mucosal lesions were induced in rats. These lesions were characterized by multiple hemorrhage red bands (patches) of different sizes along the long axis of the glandular stomach. As shown in Table 7 , the oral application (20 mg/kg) of principle saponins (5) (6) (7) (8) 10 ) exhibited protective effects againt ethanol-induced gastric lesions in rats. Especially, oleanolic acid 3-monodesmoside (6, 8, 10 ) more strongly reduced the lengths than a reference drug, omeprazole.
On the other hand, two oleanolic acid 3,28-bisdesmosides (5, 7) and two oleanolic acid 3-monodesmosides (8, 10) showed inhibitory activity on indomethacin-induced gastric mucosal lesions in rats at a dose of 20 mg/kg. The activities of oleanolic acid 3,28-bisdesmosides (5, 7) and an oleanolic acid 3-monodesmoside (8) were much more potent than those of two oleanolic acid 3-monodesmosides (6, 10).
Experimental
The instruments used to obtain physical data and the experimental conditions for chromatography were the same as described in our previous paper. (45 : 55, v/v) ] to give rutin (13, 50 mg, 0.0025%) and isorhamnetin 3-O-neohesperidoside (18, 197 mg, 0.0099%) . Fraction 4-3 (480 mg) was purified by HPLC v/v) ] to give calendasaponin B (2, 48 mg, 0.0024%). Fraction 4-4 (2 g) was purified by repeated HPLC [1) MeOH-1% aq. AcOH (75 : 25, v/v) ; 2) MeOH-1% aq. AcOH (70 : 30, v/v) ] to give calenduloside D (11, 18 mg, 0.0009%) and glycoside C (7, 1.7 g, 0.085%). ) was purified by reversed-phase silica gel column chromatography [200 g, v/v) → MeOH] and HPLC v/v) ] to give glycoside B (6, 1.6 g, 0.080%). 2f, [4] [5] [6] [7] [8] [9] [10] Calendasaponin A ( Table 7 . Effects of Glycosides A (5), B (6), C (7), D (8) , and F (10) 
